Source: ERS Skills course: Multi-disciplinary care in thoracic oncology
Disease area: -



Rating:

Share or cite this content

Citations should be made in the following way:
Levon Toufektzian (Athens, Greece). Surgeon perceptive: what is and what is not resectable stage III. ERS Skills course: Multi-disciplinary care in thoracic oncology

Member's Comments

No comment yet.

Related content which might interest you: International guidelines on stage III N2 nonsmall cell lung cancer: surgery or radiotherapy? Source: ERJ Open Res, 6 (1) 00159-2019; 10.1183/23120541.00159-2019 Year: 2020 Improved survival associated with neoadjuvant chemoradiation and surgery vs other means of treatment for NSCLC N2 patients (clinical stage IIIa and IIIb) Source: International Congress 2015 – Lung cancer therapy: clinical trials Year: 2015 Chemoradiotherapy with or without surgical resection for stage III NSCLC Source: Breathe 2010; 6: 275 Year: 2010 A single centre review of palliative chemotherapy in newly diagnosed stage IIIb and IV lung cancer patients with good performance status Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life Year: 2013 Quality of life in patients with stage IIIb NSCLC: personal evaluation Source: Eur Respir J 2002; 20: Suppl. 38, 270s Year: 2002 Management of early stage lung cancer: a surgeon's perspective Source: Eur Respir Monogr 2015; 68: 136-147 Year: 2015 Locally advanced stage nonsmallcell cancers explode in hyperglisemia: A new prognostic factors? Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 Stage IIIA/B NSCLC: rationale for multimodal diversity Source: International Congress 2017 – Rational strategies for specific treatment situations in lung cancer Year: 2017 Approaches in patients with locally advanced NSCLC: a surgeon's perspective Source: Eur Respir Monogr 2015; 68: 167-177 Year: 2015 Indication and results of surgery in stage III NSCLC Source: Annual Congress 2010 - PG23 Postgraduate Course: Case and problem-based multimodal treatment in thoracic oncology Year: 2010 Clinico-pathological prognostic factors for relapse in early stage non-small cell lung cancer after radical surgical resection Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts Year: 2013 NSCLC stage IV Source: European Multidisciplinary Conference in Thoracic Oncology 2009 Year: 2009 Resectability after two different chemotherapy regimens: results of the first step of a phase II randomised trial in initially resectable stage I – IIIa nonsmall cell lung cancer conducted by the European lung cancer working party Source: Eur Respir J 2003; 22: Suppl. 45, 162s Year: 2003 Prerequisites, potential and limits of thoracic surgery with curative intent for stage III NSCLC Source: International Congress 2019 – Locally advanced non-small cell lung cancer in 2019: novel diagnostic and therapeutic strategies to tackle complex stage III disease Year: 2019 Sublobar resections vs lobectomy for early stage lung cancer: where do we stand? Source: Virtual Congress 2020 – Lung cancer screening: are we back to the individualised decision-making process? Year: 2020 Therapeutic options for operated adenocarcinoma patients in stages I or II Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012 Modern radiotherapy as a curative treatment modality for stage III NSCLC Source: International Congress 2019 – Locally advanced non-small cell lung cancer in 2019: novel diagnostic and therapeutic strategies to tackle complex stage III disease Year: 2019